MIRA MIRA Pharmaceuticals, Inc.
Healthcare$0.97-1.81%ClosedMarket Cap: $40.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.45
P/S
0.00
EV/EBITDA
-3.77
DCF Value
$0.27
FCF Yield
-10.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-140.8%
ROA
-103.6%
ROIC
-104.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-1.1M | $-1.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-5.8M | $-6.0M | $— | — |
| FY null | $0.00 | NaN% | $-10.5M | $-10.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.3M | $-1.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.5M | $-1.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.8M | $-1.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.4M | $-2.4M | $— | — |
| FY null | $0.00 | NaN% | $-8.0M | $-7.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.1M | $-2.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.7M | $-1.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.8M | $-1.7M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-3.1M | $-5.8M | $-0.39 | — |